| Nov 7 |
Exact Sciences Third Quarter 2024 Earnings: Misses Expectations
|
| Nov 6 |
Exact Sciences: Q3 Sell-Off May Be Unjustified, But Long-Term Outlook A Concern
|
| Nov 6 |
Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount
|
| Nov 6 |
Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken?
|
| Nov 6 |
Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point
|
| Nov 6 |
Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point
|
| Nov 6 |
Exact Sciences Stock Down on Q3 Earnings & Revenue Miss, '24 View Cut
|
| Nov 6 |
Q3 2024 Exact Sciences Corp Earnings Call
|
| Nov 6 |
Exact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
|
| Nov 6 |
Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight
|
